Systems And Methods For Treating A Carotid Artery
US-2017312491-A1 · Nov 2, 2017 · US
US12128204B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12128204-B2 |
| Application number | US-201916530783-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 2, 2019 |
| Priority date | Aug 12, 2010 |
| Publication date | Oct 29, 2024 |
| Grant date | Oct 29, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Systems and methods are adapted for treating the carotid artery. The systems include interventional catheters and blood vessel access devices that are adapted for transcervical insertion into the carotid artery. Embodiments of the systems and methods can be used in combination with embolic protection systems including blood flow reversal mechanisms, arterial filters, and arterial occlusion devices.
Opening claim text (preview).
The invention claimed is: 1. A method of accessing and treating a carotid artery, the method comprising: inserting an arterial access device into an artery, wherein the arterial access device comprises a distal sheath, an aspiration port communicating with an internal lumen of the distal sheath, and a proximal hemostasis valve assembly providing access to the internal lumen of the distal sheath; the hemostasis valve assembly comprising: (a) a housing defining an internal chamber that communicates with the internal lumen of the distal sheath, wherein the internal chamber is adapted to contain a liquid; (b) a first seal member that seals the internal chamber from the internal lumen of the distal sheath, the first seal member having a central passageway that opens for passage of an interventional device into the internal lumen of the distal sheath from the internal chamber, wherein the central passageway is closed in a default state to prevent passage of fluid across the first seal member; (c) wherein, when the internal chamber is filled with liquid or gel, the liquid or gel prevents air from entering the internal lumen of the distal sheath via the hemostasis valve assembly when the internal lumen of the distal sheath is aspirated, via the aspiration port; a second seal member, wherein the second seal member is positioned on a proximal end of the internal chamber and the first seal member is positioned on a distal end of the internal chamber so that the first seal member and second seal member define the internal chamber therebetween and can enclose liquid or gel within the internal chamber, and wherein the first seal member and second seal member are aligned along a common, straight axis; and wherein the internal chamber is pre-filled with liquid prior to a first use of the arterial access device. 2. A method as in claim 1 , wherein a proximal end of the internal chamber is open to atmosphere, and wherein the internal chamber has a size such that surface tension of liquid or gel in the internal chamber maintains the liquid or gel within the internal chamber. 3. A method as in claim 1 , further comprising: inserting an interventional device through the internal chamber of the hemostasis valve assembly, across the first seal member, and into the internal lumen of the distal sheath; and coupling an introducer to the interventional device so as to provide the interventional device with sufficient columnar stiffness to pass entirely through the internal chamber and into the hemostasis valve assembly. 4. A method as in claim 3 , wherein the introducer is removably coupled to the interventional device. 5. A method as in claim 1 , wherein the arterial access device further comprises a flush port having a lumen in communication with the internal chamber of the hemostasis valve assembly, the flush port adapted to inject liquid or gel into the internal chamber of the hemostasis valve assembly. 6. A method as in claim 1 , wherein the arterial access device further comprise a shunt fluidly connected to the arterial access device, wherein the shunt provides a pathway for blood to flow in a retrograde direction from the arterial access device to a return site. 7. A method as in claim 6 , wherein a flow control assembly is coupled to the shunt and adapted to regulate blood flow through the shunt between at least a first blood flow state and at least a second blood flow state, wherein the flow control assembly includes one or more components that interact with the blood flow through the shunt. 8. A method as in claim 7 , wherein the flow control assembly includes a flow resistance element adapted to adjust a resistance of blood flow through the shunt. 9. A method as in claim 1 , further comprising inserting a venous return device into a vein, and wherein a shunt fluidly connects the arterial access device to the venous return device such that the blood flows through the shunt from the common carotid artery to the vein. 10. A method as in claim 6 , wherein the shunt is adapted to be connected to an external receptacle such that the blood flows from the common carotid artery through the shunt to the external receptacle.
Arterio-venous shunts or fistulae · CPC title
with a tubular diaphragm constrictable by radial fluid force · CPC title
Valves actuated by a secondary fluid, e.g. hydraulically or pneumatically actuated valves · CPC title
without means for adjusting the seal opening or pressure (A61M39/0693 takes precedence) · CPC title
entirely comprised between the two sides of the opening · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.